Product Images Humira
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 37 images provide visual information about the product associated with Humira NDC 83457-554 by Cordavis Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a comparison chart showing the response rate to the ASAS 20 criteria between a placebo group (N=107) and a group treated with HUMIRA (N=208) over a span of 24 weeks. The response rate is observed at different time points.*
This is a description of the HUMIRA Single-Dose Pen. It includes details such as the gray cap, white needle sleeve, plum-colored cap, inspection window for the needle, and an activator button.*
This is a description of a medical product called HUMIRA PEN, which is a subcutaneous medication containing adalimumab. It comes in a carton with 2 single-dose prefilled pens for use by patients. The medication is intended for subcutaneous use only and each pen contains 1 ml solution. Pharmacists are required to provide patients with an enclosed Medication Guide. To open the package, instructions from abbvie can be followed.*
This is information about a medication called "HUMIRA PEN" containing adalimumab for subcutaneous use. The medication comes in a package that includes 2 single-dose prefilled pens. The text also requests pharmacists to provide the included Medication Guide to each patient receiving the medication. It mentions that the pen does not contain natural rubber latex and provides details about the pen's components. The packaging information implies that each pen should be used as directed.*
This text appears to be a medication label for Humira (adalimumab) containing information about the dosage and administration for subcutaneous use. It includes details about the content, such as the prefilled syringes with a specific dose of 10 mg/0.4 mL of adalimumab and instructions for use. It also mentions the requirement for patients to receive a Medication Guide and notes on the packaging materials.*
This is a description of a medication called HUMIRA® in a prefilled syringe form with 20 mg/0.2 mL of adalimumab for subcutaneous use. Each package contains 2 single-dose prefilled syringes and a Medication Guide. The syringe cover is not made with natural rubber latex. Patients are instructed to visit HUMIRA.COM for more information. The medication is for prescription use only.*
This description provides information about a medication called HUMIRA, which comes in the form of two single-dose prefilled syringes containing adalimumab. The dosage strength is 40 mg/0.4 mL. It is intended for subcutaneous use only. The medication is manufactured for Rx only and the enclosed Medication Guide should be given to each patient. The syringes are not made with natural rubber latex. The information also includes the manufacturer's details and instructions to visit HUMIRA.COM for more information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.